SEC Form 4 · accession 0001250853-18-000125
Kindred Biosciences, Inc. · KIN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond Townsend
Director
Period of report
Sep 25, 2018
Accepted (ET)
Sep 27, 2018 · 8:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 25, 2018 | S | 115 | $13.80 | D | 27,813 | D | |
| Common Stock | Sep 26, 2018 | S | 2,885 | $13.30 | D | 24,928 | D |
Table II — derivative securities
No Table II lines on this filing.